Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-04-25 | 2025-03-13 | 226174 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-06-07 | 2025-04-28 | 229945 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136314 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86846 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211985 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-22 | 2024-12-19 | 220267 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-28 | 2024-09-19 | 223853 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2024-07-04 | 2025-01-16 | 232232 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2024-07-18 | 2024-09-19 | 233273 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-01-09 | 2020-06-25 | 102890 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2020-01-09 | 2020-08-21 | 102931 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |
| TEVA-TENOFOVIR | 300MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256088 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256104 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |